Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 140 (RNA5SP140) is classified as a processed rRNA pseudogene. While the canonical 5S ribosomal RNA gene encodes a key structural and functional component of the ribosome essential for protein synthesis, RNA5SP140 does not encode a functional product and lacks protein-coding capacity due to mutations or genomic rearrangements that occurred during its formation. Pseudogenes such as RNA5SP140 are often used in the annotation of genomic regions but are not themselves functional molecules, nor do they serve as conventional therapeutic targets, receptors, enzymes, channels, or transporters. There is no evidence that RNA5SP140 participates directly in regulatory, signaling, or disease-associated pathways, and it is not targeted by drugs nor considered a biomarker for medical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 140 (RNA5SP140).